Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10890127Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pharmacology
NIH Funding · FY2026
Linked Award Amount
$1.6M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#4,876
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Libin Xu as a PI. Multi-PI records show the full award amount for context.
- 5R01ES035021-03R01Impact of benzalkonium chloride on gut microbiome and gut-liver interactions$648.7Kaward amount
- 5R01AI136979-08R01Contribution of altered cell envelope metabolism to resistance to cell envelope-targeting antimicrobials in MRSA$550.2Kaward amount
- $357.6Kaward amount
Award organization
Organizations that administered FY2026 awards listing Libin Xu as a PI.
FY2026 award administered by University of Washington (WA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Washington
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #4991
- 2024Entered Top 25% NationallyRanked #4991
- 2025R01 Grant Holder
- 2026$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Libin Xu.